A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas

Completed · Phase 1

Conditions studied: Pancreatic Neoplasm

In brief

This study aims to seek evidence that activation of certain cells of the immune system will be safe and well tolerated in combination with cytotoxic chemotherapy. Preliminary evidence of clinical anti-tumor activity will be sought.

Key facts

Study ID

NCT00711191

Run by

Hoffmann-La Roche

People needed

22

Starts

2008-06-01

Expected to finish

2011-01-01

Last updated by the study team

2013-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1st-line surgically incurable cancer of the pancreas
• ECOG(Eastern Cooperative Oncology Group) performance status 0-1

You may not qualify if…

• Previous systemic therapy for pancreas cancer
• History of cancer-associated blood clots
• History of autoimmune disease

Where it is running

• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.